The list compiled by Alantra, an international financial services company, ranks companies according to their revenue growth over the past two years.

Richmond Pharmacology is delighted with the recognition and features in the lists top twenty at number 17. The Alantra Pharma Fast 50 is in its fifth year and was launched to recognise and celebrate successful business within the UK life sciences market.

The list includes analysis of businesses grouped into four distinct sub-sectors – Technology; Analytics, insights and communication; Pharma outsourcing; and Develop, wholesale and supply.

Richmond Pharmacology is categorised in the publication as a Contract research organisation providing services from design to delivery of early phase clinical trials.

Read the report in full

Latest news

Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects

December 4, 2023
Groundbreaking research paper authored by Dr. Georg Ferber, Dr. Dilshat Djumanov, Dr. Ulrike Lorch, Dr. Edward Jackson, Dr. Joao Almeida Melo, Mr. James Rickard, and Dr. Jorg Taubel. 
Read more

Richmond Pharmacology becomes Richmond in Brand Refresh

December 1, 2023
Refreshed brand reflects company’s growth over 22 years and renewed commitment to turning hope into reality for patients.
Read more


The 44th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

14 – 16 December 2023
We are thrilled to share our participation in the 44th Annual Meeting of the Japan Society of Clinical Pharmacology.
View event